Dr. Edris Zaid Alderwish, MD

Dr. Alderwish practices at Adventist Health White Memorial in Los Angeles, California, part of Adventist Health.

Dr. Alderwish's NPI, 1285959858, was assigned on April 7, 2010. Dr. Alderwish graduated from American University of Antigua College of Medicine in 2010. Dr. Alderwish holds California license A172624.

Dr. Alderwish's primary practice is Adventist Health White Memorial, at 1720 Cesar E Chavez Avenue, Los Angeles, CA 90033 in Los Angeles County. The practice phone is (323) 268-5000.

Dr. Alderwish's primary practice is Adventist Health White Memorial in Los Angeles, California, part of Adventist Health. The medical group on file is Adventist Health Physicians Network. Dmand AI also links Dr. Alderwish to 10 more medical groups, 4 group practices and clinics and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Alderwish practices, 6 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Alderwish's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Alderwish is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Alderwish's licenses on file in 2 states: California and New York.

Dmand AI lists angioplasty and cardiac catheterization among the conditions Dr. Alderwish treats.

CMS data shows 892 Medicare services from Dr. Alderwish across 12 procedure codes in 2024, for 149 Medicare patients. Medicare paid $85,946 for them.

CMS counts 149 Medicare patients who saw Dr. Alderwish in 2024. The largest group is 65 to 74, with 60 patients. 75% of them have diabetes, and 75% have high blood pressure. 91% are also on Medicaid. Their average risk score is 4.09, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Alderwish's median patient age at 64, with 48% women.

In 2024, Dr. Alderwish wrote 1,160 Medicare Part D claims for 123 patients. 59% of them were for generic drugs. CMS names the drug for 1,063 of them, across 21 drugs with 11 or more claims each, at $271,386 in total drug cost. In 2023, CMS named 610 claims across 17 drugs.

Dr. Alderwish accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 22 procedures of leg revascularization (restoring blood flow) by Dr. Alderwish, more than 82% of the clinicians it reports for that procedure.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Alderwish, published from 2013 to 2020. Dr. Alderwish's most frequent co-authors are Neil E. Bernstein, MD, Kabir Bhasin, MD and Claire Emily Reynolds Carrazco, DO.

CMS Open Payments shows 701 general payments to Dr. Alderwish from 37 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 37% of the total. ShockWave Medical, Inc paid the most, $45,607.

Dr. Alderwish graduated from American University of Antigua College of Medicine in 2010. Dr. Alderwish is a member of ACC and Society of Cardiovascular Computed Angiography.

Dr. Alderwish is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.